Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Learn valuable wealth building strategies from top advisors to effectively enhance your financial portfolio. Discover expert insights today!
20,021 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
AI investments in data centers lift NVENT Electric, shown as a leaner Vertiv-like play for infrastructure suppliers. ...
Oracle is slated to post Q3 results after the market closes, with a 5:00 p.m. ET conference call. Here’s what to watc...
A leading fintech player reveals a real-world crypto use case that could reshape how merchants and consumers transact...
Solana is under renewed selling pressure as negative funding rates persist and on-chain inflows surge. Analysts warn ...
OpenAI CEO Sam Altman acknowledges AI is shifting the traditional labor-capital balance, highlighting job fears as au...
Pixelworks' 2025 earnings cycle highlights a niche semiconductor with rising AI-driven display capabilities. This art...
SM Energy surged 37% year-to-date after finalizing its Civitas Resources merger, but a quarterly miss underscored lev...
When a CEO disposes of stock, investors want context. This deep dive explains what fastly's sold company shares could...
Constellation Energy has closed the Calpine deal and now commands the country’s largest private-sector power fleet, w...
Two discount retailers face off for 2026 returns, with Dollar Tree highlighting a store-format push and Dollar Genera...
Is the Trump bull market about to end, or is this a chapter in a longer market cycle? This guide blends history, data...